| 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2023-056 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | | 西安蓝晓科技新材料股份有限公司 关于使用自有外汇存款、银行承兑汇票支付募集资金投资 项目并以募集资金等额置换的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开了第四届董事会第二十一次会议和第四届监事会第十九次会议审议通过 了《关于使用自有外汇存款、银行承兑汇票支付募集资金投资项目并以募集资金 等额置换的议案》，同意公司在募集资金投资项目实施期间，使用自有外汇资金、 银行承兑汇票支付募集资金投资项目中的应付款项，并定期从募集资金专户划转 等额资金至公司其他账户。现将相关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意西安蓝晓科技新材料股份有限公司向 不特定对象发行可转换公司债券注册的批复》（证监许可〔2023〕628 号）核准， 公司向不特定对象发行可转换公 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开了 第四届董事会第二十一次会议和第四届监事会第十九次会议，审议通过了《关于开展外 汇套期保值业务的议案》，同意公司（含子公司）开展外汇套期保值业务，金额不超过 5,000 万美元（或等值外币）。现将相关事项公告如下： 一、开展外汇套期保值业务的目的 证券代码：300487 证券简称：蓝晓科技 公告编号：2023-054 债券代码：123195 债券简称：蓝晓转 02 西安蓝晓科技新材料股份有限公司 关于开展外汇套期保值业务的公告 公司国际贸易业务采用外币结算，伴随着公司海外业务的增加，汇率波动对公司经 营业绩造成一定影响。为有效规避外汇市场风险，进一步提高公司应对外汇波动风险的 能力，防范汇率大幅波动对公司造成的不良影响，更好维护公司及全体股东的利益。公 司（含子公司）拟与银行等金融机构开展外汇套期保值业务，主动应对外汇汇率波动的 风险，增强财务稳健性。 二、拟开展的外汇套期保值业务的基本情况 1.主要涉及币种及业务品种 公司 ...

| 证券代码：300487 | 证券简称：蓝晓科技 公告编号：2023-057 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | 西安蓝晓科技新材料股份有限公司 关于使用募集资金置换预先已投入募投项目及已支付 发行费用的自筹资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开了第四届董事会第二十一次会议和第四届监事会第十九次会议，审议通过 了《关于使用募集资金置换预先已投入募投项目及已支付发行费用的自筹资金的 议案》，同意公司以募集资金置换预先已投入募投项目及已支付发行费用共计 8,393.92 万元。现将相关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意西安蓝晓科技新材料股份有限公司向 不特定对象发行可转换公司债券注册的批复》（证监许可〔2023〕628 号）核准， 公司向不特定对象发行可转换公司债券5,460,645张，每张面值为人民币100元， 按面值发行，发行总额为人民币 546,064,5 ...

| 证券代码：300487 | 证券简称：蓝晓科技 公告编号：2023-051 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转02 | 西安蓝晓科技新材料股份有限公司 4.招标人：国投新疆罗布泊钾盐有限责任公司（以下简称"国投罗钾"） 二、本次中标对公司的影响 本次中标金额为人民币 62,224,500.00 元，约占 2022 年度经审计营业收入总 额的 3.24%，不会对公司的生产经营产生重大影响。此次中标项目与已公告的综 合利用工程吸附系统采购项目（公告编号：2023-008）同属新疆地区罗布泊盐湖 首个产业化提锂项目，项目的实施将为公司吸附法盐湖提锂案例又丰富新的资源 属性，同时再次强化公司在提锂领域的技术实力，并对公司资源及新能源业务领 域发展起到积极影响。 2.中标单位：西安蓝晓科技新材料股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 3.中标金额：62,224,500.00 元 风险提示：本次项目中标尚未签订合同并完成交货，仍然存在一定的不确定 性和风险。敬请广大投资者谨慎决策，注意防范投资风险。 ...

Financial Performance - The company's annual revenue for 2022 reached 1.92 billion yuan, representing a year-on-year growth of 60.69%[2] - Net profit for 2022 was 540 million yuan, an increase of 72.9% compared to the previous year, achieving a historical high[2] - The company's operating revenue for 2022 was approximately CNY 1.92 billion, representing a 60.69% increase compared to CNY 1.19 billion in 2021[23] - Net profit attributable to shareholders for 2022 was approximately CNY 537.51 million, a 72.91% increase from CNY 310.86 million in 2021[23] - The cash flow from operating activities for 2022 was approximately CNY 723.75 million, showing a significant increase of 106.61% compared to CNY 350.30 million in 2021[23] - Basic earnings per share for 2022 were CNY 1.63, an increase of 13.99% from CNY 1.43 in 2021[23] - The gross profit margin for the company was 43.99%, with the gross margin for adsorption materials increasing by 1.17 percentage points[81] - The company achieved a revenue of 1.92 billion yuan in 2022, a year-on-year increase of 60.7%[79] - The net profit attributable to shareholders reached 540 million yuan, reflecting a 73.0% year-on-year growth[79] Cash Flow and Assets - The net cash flow at the end of the period was 724 million yuan, a significant increase of 106.6% year-on-year, supporting new technology development and high-quality operations[2] - Total assets at the end of 2022 reached approximately CNY 4.56 billion, a 46.97% increase from CNY 3.10 billion at the end of 2021[23] - The company's total assets grew to 4.563 billion yuan, a 47% increase year-on-year[83] - The net increase in cash and cash equivalents was ¥488,220,574.89, reflecting a growth of 183.29% due to increased cash receipts from sales[114] Market Position and Strategy - The company has a total of 2.7 billion yuan in cumulative orders as of the end of 2022, with a strong order structure focused on lithium extraction and life sciences, suggesting robust growth momentum for 2023[2] - The company is strategically positioning itself in both existing and emerging markets to capitalize on the growing demand for high-tech materials and applications[2] - The company is expanding its international business, which is becoming a significant portion of its operations, and is developing effective market expansion strategies to mitigate regulatory risks[10] - The company is actively pursuing international expansion and has been enhancing its market share through strategic investments in high-quality production platforms[33] - The company has signed a total of 10 industrial-scale projects with a cumulative lithium carbonate/hydroxide capacity of 78,000 tons and a total contract value of approximately 2.6 billion yuan, with 5 projects completed and operational[85] Research and Development - The company emphasizes continuous innovation and has invested in talent development to enhance its competitive edge in the adsorption separation technology sector[2] - The company has a research and development team of over 200 members, covering various fields such as polymer materials, organic synthesis, and biomedical applications[72] - Research and development expenses amounted to 121 million yuan in 2022, accounting for 6.3% of revenue, with significant innovations in metal resources and life sciences[91] - The company is focusing on optimizing production organization and enhancing management quality to meet market demand effectively[90] Product Development and Applications - The company is expanding its product applications across multiple industries, including metal resources and life sciences, to mitigate risks associated with market fluctuations[5] - The company is focusing on the industrialization of its adsorption separation technology, which has applications across multiple sectors, although current revenue impact is limited[12] - The company has developed advanced adsorption separation technology for lithium extraction, addressing the challenges of high magnesium-lithium ratios in Chinese salt lakes[51] - The company has developed a new generation of lithium adsorbents, enhancing performance and expanding application in the lithium extraction process[91] Risk Management - The company faces risks related to market competition and the need for continuous product development to maintain its market share and profitability[6] - The company is addressing market competition risks by continuously developing new products and enhancing existing product performance to maintain its competitive edge[143] - The company is strengthening accounts receivable management to mitigate risks associated with extended customer payment cycles[144] - The company is diversifying its product applications across various sectors to manage risks associated with changes in downstream application fields[145] Governance and Compliance - The company maintains a robust internal governance structure, ensuring compliance with relevant laws and protecting shareholder interests[154] - The board of directors consists of 9 members, including 3 independent directors, and operates through specialized committees to ensure effective governance[157] - The company emphasizes transparency in information disclosure, ensuring timely and accurate communication with investors[160] - The company has established a comprehensive internal control system to enhance governance and ensure operational objectives are met[161] Employee Development and Management - The company emphasizes the importance of retaining core technical personnel to maintain its competitive advantage and has implemented a talent management system to optimize human resources[9] - The company is focusing on talent development and recruitment from top universities to strengthen its R&D capabilities[92] - The company emphasizes employee training, implementing a comprehensive training system that includes various programs such as onboarding, skills training, and management development[195] - The company has a total of 6 employees with a doctoral degree, 76 with a master's degree, and 342 with a bachelor's degree, reflecting a well-educated workforce[193]

证券代码：300487 证券简称：蓝晓科技 债券代码：123195 债券简称：蓝晓转 02 西安蓝晓科技新材料股份有限公司 投资者关系活动记录表 编号：2023-002 | --- | --- | --- | |----------|--------------------------------------|----------------------------------------------------------------| | | □特定对象调研 | □分析师会议 | | 投资者关 | □媒体采访 | 业绩说明会 | | 系活动 | □新闻发布会 □ | 路演活动 | | 类别 | □现场参观 | | | | □其他 | | | 参与单位 | 蓝晓科技 2022 | 年度网上业绩说明会采用网络远程方式进行，面向全体 | | 名称及人 | | | | 员姓名 | 投资者 | | | 时间 | 2023 年 5 月 16 日 15:00-17:00 | | | | 公司通过全景网"投资者关系互动平台"（ | https://ir.p5w.net）采 | | 地点 | | | | | 用网络远程的方 ...

2022 年度业绩说明会"的公告 本公司及全体董事会成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）《2022 年年度报 告》全文及其摘要已于 2023 年 4 月 26 日披露。为促进上市公司规范运作、健康 发展，增强公司信息透明度，加强与广大投资者沟通交流，进一步提升投资者关 系管理水平，陕西上市公司协会根据陕西证监局工作部署，联合深圳市全景网络 有限公司举办"2023 年陕西辖区上市公司投资者集体接待日暨 2022 年度业绩说 明会活动"。 届时，公司董事长高月静女士、财务总监安源女士、董事会秘书于洋先生、 独立董事强力先生、保荐代表人雒晓伟先生将通过互动平台与投资者进行网络沟 通和交流，欢迎广大投资者踊跃参加。 活动时间：2023 年 5 月 16 日 15:00-17:00。 | 证券代码：300487 | 证券简称：蓝晓科技 公告编号：2023-038 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转02 | 西安蓝晓科技新材料股份有限公司 关于参加"2023 年陕西辖区上市公司投资者集 ...

Financial Performance - The company's annual revenue for 2022 reached 1.92 billion yuan, representing a year-on-year growth of 60.69%[2] - Net profit for 2022 was 540 million yuan, an increase of 72.9% compared to the previous year, marking a historical high[2] - The company's operating revenue for 2022 was approximately CNY 1.92 billion, representing a 60.69% increase compared to CNY 1.19 billion in 2021[24] - Net profit attributable to shareholders for 2022 was approximately CNY 537.51 million, a 72.91% increase from CNY 310.86 million in 2021[24] - The cash flow from operating activities for 2022 was approximately CNY 723.75 million, showing a significant increase of 106.61% compared to CNY 350.30 million in 2021[24] - Basic earnings per share for 2022 were CNY 1.63, a 13.99% increase from CNY 1.43 in 2021[24] - The company's total production of adsorption materials was 48,500 tons in 2022, a year-on-year increase of 43%, while sales volume reached 43,200 tons, up 34% year-on-year[88] - The life sciences segment achieved sales revenue of 318 million yuan in 2022, representing a year-on-year growth of 58%[86] - The company's overseas sales revenue reached 404 million yuan in 2022, an increase of 46.8% year-on-year, driven by growth in high-end drinking water, metal extraction, and biopharmaceuticals[86] Cash Flow and Assets - The net cash flow at the end of the period was 724 million yuan, a significant increase of 106.6% year-on-year, supporting new technology development[2] - The total assets of the company amounted to 4.56 billion yuan, with a net asset return rate of 22.63%, up by 6.2% year-on-year[2] - The company's total assets grew to 4.563 billion yuan, a 47% increase year-on-year, while total liabilities increased by 81.7% to 1.826 billion yuan[84] - The company's cash and cash equivalents increased by 183.29% to ¥488,220,574.89, primarily due to higher cash receipts from sales[114] - The total assets at the end of 2022 were significantly impacted by an increase in cash and accounts receivable, with cash constituting 29.49% of total assets[117] Research and Development - The company is focusing on innovation and has seen over 20% of its annual revenue contribution from technologies developed in the past 15 years[3] - Research and development expenses amounted to 121 million yuan in 2022, accounting for 6.3% of total revenue, reflecting the company's commitment to innovation[90] - The company has established a research and development team of over 200 members, covering various fields such as polymer materials, organic synthesis, and biomedical applications[74] - The company has achieved important industrial breakthroughs in electronic-grade and nuclear-grade ultra-pure water fields, addressing critical supply chain issues[44] - The company has developed a modular adsorption separation technology for lithium extraction, which is being promoted in various regions including Tibet and South America, addressing the challenges of low lithium content in Chinese salt lakes[54] Market Expansion and Strategy - The company is expanding its international business, with a significant increase in the proportion of international market business volume, while implementing effective market development plans to reduce regulatory risks[11] - The company is strategically diversifying its product applications across various industries, including metal resources and life sciences, to mitigate risks from market fluctuations[9] - The company has signed multiple industrialization orders for lithium extraction from salt lake brine, with a total capacity of 78,000 tons of lithium carbonate/hydroxide, five of which have already commenced operations[54] - The company is focusing on expanding its system integration device business, which has become a significant profit growth point due to increased collaboration with innovative clients[48] - The company plans to expand its international strategy, targeting high-end brands in existing markets and establishing a sales network in countries like Belgium, Germany, and Argentina[139] Product Development and Innovation - The company has developed adsorption separation technology applicable across multiple fields, although current revenue impact is limited as these new businesses are still in the early stages of market development[13] - The company has developed two types of resins for vitamin B12 purification, enhancing yield and impurity removal efficiency[112] - The company launched a new protein A affinity filler in the life sciences sector, which successfully passed customer trials and is being used in ongoing projects[91] - The company has achieved market commercialization of its supercoiled plasmid purification series fillers and processes, enhancing its product offerings in the biopharmaceutical sector[111] - The company is focusing on developing high-end brands with technical characteristics to seek market breakthroughs and gradually increase market share[87] Risk Management - The company is committed to improving internal controls and management efficiency to adapt to its rapid growth and complex organizational structure[6] - The company is addressing the risk of increased asset depreciation due to the rapid growth of fixed assets by enhancing market expansion efforts to ensure timely project benefits[12] - The company is enhancing accounts receivable management to mitigate risks associated with extended customer settlement periods[147] - The company is facing management risks due to rapid business expansion, which may complicate organizational structure and management systems[145] - The company is at risk of intensified market competition as more players enter the emerging application fields of adsorption separation technology[146] Shareholder and Governance - The company plans to distribute a cash dividend of 6.42 CNY per 10 shares and will increase capital reserves by 5 shares for every 10 shares held[13] - The company has established a performance evaluation and incentive mechanism linking senior management compensation to business performance[160] - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations[156] - The company held three shareholder meetings in 2022, with participation rates of 55.51%, 56.08%, and 59.74% respectively[171] - The company is committed to maintaining compliance with regulations and ensuring the protection of shareholder rights[191] Employee Management - The company is focusing on talent recruitment and aims to create a positive cycle between talent and platform to boost R&D innovation[141] - The total number of employees at the end of the reporting period was 1,311, with 704 in the parent company and 607 in major subsidiaries[195] - The company actively implements a training program for employees, covering various areas such as onboarding, business skills, management enhancement, and safety training[198] - The company has a profit distribution policy that emphasizes reasonable returns to investors while ensuring sustainable development, with a minimum cash dividend ratio of 30% of the average distributable profit over three years[200] - The company has no outsourced labor, indicating a focus on internal workforce management[199]

Financial Performance - The company's revenue for Q1 2023 was ¥500,784,017.65, representing a 50.90% increase compared to ¥331,861,373.81 in the same period last year[3] - Net profit attributable to shareholders for Q1 2023 was ¥133,874,457.07, a 66.28% increase from ¥80,512,255.70 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥129,254,652.49, up 66.11% from ¥77,814,793.53 in the previous year[3] - Operating profit for the current period was ¥157,251,835.50, compared to ¥90,381,599.62 in the previous period, marking an increase of approximately 74.0%[19] - Net profit for the current period was ¥135,479,267.39, up from ¥78,700,359.47, indicating a growth of around 72.2%[19] Earnings and Shares - Basic and diluted earnings per share for Q1 2023 were both ¥0.4, an increase of 8.11% from ¥0.37 in the previous year[3] - Basic earnings per share increased to ¥0.40 from ¥0.37, representing an increase of approximately 8.1%[20] - The company reported a total of 33,292,041.00 shares in lock-up at the end of the period, down from 33,427,791.00 shares at the beginning, indicating a decrease of approximately 0.40%[11] Cash Flow and Liquidity - The company's cash flow from operating activities for Q1 2023 was ¥129,317,646.12, reflecting a 15.29% increase from ¥112,166,192.25 in the same period last year[3] - Cash flow from operating activities generated ¥501,664,216.10, compared to ¥417,648,123.30 in the previous period, an increase of about 20.1%[21] - The total cash and cash equivalents at the end of the period reached 1,327,720,347.80, up from 856,020,294.47 in the previous year[23] - The cash and cash equivalents stood at RMB 1,424,987,846.11, compared to RMB 1,345,405,175.84 at the start of the year, representing a growth of approximately 5.89%[14] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥4,716,326,079.50, a 3.37% increase from ¥4,562,618,498.44 at the end of the previous year[3] - The total liabilities of the company were RMB 1,829,351,011.25, slightly up from RMB 1,826,329,565.16, showing a marginal increase of 0.06%[16] - The company's total current assets reached RMB 3,348,261,049.32, up from RMB 3,190,402,838.79 at the beginning of the year, indicating an increase of about 4.94%[15] - The inventory as of March 31, 2023, was RMB 998,582,559.56, up from RMB 962,717,206.08 at the beginning of the year, indicating an increase of approximately 3.71%[14] Expenses - Research and development expenses for Q1 2023 were ¥29,808,280.53, a 62.27% increase from ¥18,369,672.92 in the same period last year[6] - The company reported a significant increase in sales expenses, which rose by 208.45% to ¥17,215,636.20 due to increased share-based payments[6] - Total operating costs increased to ¥343,263,033.70 from ¥242,512,900.08, reflecting a rise of about 41.6%[18] - Tax expenses for the current period were ¥21,753,128.11, compared to ¥11,577,041.75 in the previous period, indicating an increase of approximately 88.1%[19] Investment Activities - The company invested 30,000,000.00 in capital expenditures during the quarter, a significant increase compared to 5,121,818.17 in the previous year[23] - Cash flow from investing activities totaled ¥30,345,000.00, up from ¥20,337,883.56, reflecting a growth of approximately 49.5%[22] - The net cash flow from investment activities was -10,833,171.80, compared to 15,216,065.39 in the previous year, indicating a significant decrease in investment returns[23] Financing Activities - Cash inflow from financing activities totaled 62,286,334.68, an increase from 52,535,100.00 in the same period last year[23] - The net cash flow from financing activities was 44,131,111.07, slightly down from 49,231,501.04 year-over-year[23] - The company plans to issue convertible bonds to unspecified investors, as approved in the board meeting on April 12, 2023[13] Other Information - The company received government subsidies amounting to ¥4,189,521.27 during the reporting period[4] - The first quarter report was not audited, which may affect the reliability of the financial data presented[23] - The company experienced a negative impact of -5,548,411.84 from exchange rate fluctuations on cash and cash equivalents[23] - The cash outflow for debt repayment was 17,800,000.00, compared to 3,000,000.00 in the previous year, showing increased debt management efforts[23]